APG
GEN

Abacus Planning Group’s Genesis Healthcare, Inc. GEN Stock Holding History

Abacus Planning Group’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-40,240
Closed -$20K – 202
2020
Q4 		$20K Hold
40,240
– – 0.01% 187
2020
Q3 		$22K Hold
40,240
– – 0.01% 171
2020
Q2 		$28K Hold
40,240
– – 0.01% 163
2020
Q1 		$34K Hold
40,240
– – 0.02% 155
2019
Q4 		$66K Hold
40,240
– – 0.03% 170
2019
Q3 		$45K Hold
40,240
– – 0.02% 168
2019
Q2 		$50K Buy
+40,240
New +$51.2K 0.03% 161

Other funds holding GEN

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Abacus Planning Group's GEN Position: Q1 2021 in Review

Abacus Planning Group sold out of Genesis Healthcare, Inc. (GEN) in Q1 2021, closing a stake of 40,240 shares — an estimated $20K sold.

Abacus Planning Group first reported a position in GEN in Q2 2019 and held it in 7 quarters. The position peaked at $66K in Q4 2019. 8 funds tracked by Wall St. Rank hold GEN as of Q1 2021.

  • Abacus Planning Group reported no remaining Genesis Healthcare, Inc. position as of Q1 2021 after selling out during the quarter.
  • Abacus Planning Group sold 40,240 Genesis Healthcare, Inc. shares in Q1 2021, an estimated $20K.
  • Abacus Planning Group first reported a position in Genesis Healthcare, Inc. in Q2 2019 and held it in 7 quarters.
  • Abacus Planning Group's Genesis Healthcare, Inc. position peaked at $66K in Q4 2019.
  • 8 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2021.

Based on Abacus Planning Group's 13F filing for Q1 2021, filed 27 Apr 2021.